Global and United States Codeine Market Insights, Forecast to 2027

Publisher Name :
Date: 06-Sep-2021
No. of pages: 153
Inquire Before Buying

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.

Market Analysis and Insights: Global and United States Codeine Market

This report focuses on global and United States Codeine market.

In 2020, the global Codeine market size was US$ 288.6 million and it is expected to reach US$ 194.4 million by the end of 2027, with a CAGR of -5.5% during 2021-2027. In United States the Codeine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Codeine Scope and Market Size

Codeine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Codeine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Codeine market size by players, by Ingredient, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Ingredient

- Single-ingredient Codeine

- Multi-ingredient Medications

Segment by Application

- Narcotic Analgesic

- Antitussive

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Taiji

- Mallinckrodt

- TEVA

- Johnson & Johnson

- Medreich

- Sanofi Aventis

- Cipla

- Hikma

- Pharmaceutical Associates

- Novartis

- Apotex

- Mylan

- Aristo Pharma GmbH

- Lannett Company

- Laboratoire Riva

Global and United States Codeine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Codeine Product Introduction
1.2 Market by Ingredient
1.2.1 Global Codeine Market Size Growth Rate by Ingredient
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Market by Application
1.3.1 Global Codeine Market Size Growth Rate by Application
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Codeine Market Size, Estimates and Forecasts
2.1.1 Global Codeine Revenue 2016-2027
2.1.2 Global Codeine Sales 2016-2027
2.2 Global Codeine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Codeine Historical Market Size by Region (2016-2021)
2.3.1 Global Codeine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Codeine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Codeine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Codeine Sales Forecast by Region (2022-2027)
2.4.2 Global Codeine Revenue Forecast by Region (2022-2027)
3 Global Codeine Competitor Landscape by Players
3.1 Global Top Codeine Manufacturers by Sales
3.1.1 Global Codeine Sales by Manufacturer (2016-2021)
3.1.2 Global Codeine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Codeine Manufacturers by Revenue
3.2.1 Key Codeine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Codeine Revenue by Manufacturers (2016-2021)
3.2.3 Global Codeine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Codeine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Codeine Revenue in 2020
3.2.6 Global Codeine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Codeine Price by Manufacturers
3.4 Global Codeine Manufacturing Base Distribution, Product Types
3.4.1 Codeine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Codeine Product Type
3.4.3 Date of International Manufacturers Enter into Codeine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Ingredient (2016-2027)
4.1 Global Codeine Market Size by Ingredient (2016-2021)
4.1.1 Global Codeine Sales by Ingredient (2016-2021)
4.1.2 Global Codeine Revenue by Ingredient (2016-2021)
4.1.3 Codeine Average Selling Price (ASP) by Ingredient (2016-2021)
4.2 Global Codeine Market Size Forecast by Ingredient (2022-2027)
4.2.1 Global Codeine Sales Forecast by Ingredient (2022-2027)
4.2.2 Global Codeine Revenue Forecast by Ingredient (2022-2027)
4.2.3 Codeine Average Selling Price (ASP) Forecast by Ingredient (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Codeine Market Size by Application (2016-2021)
5.1.1 Global Codeine Sales by Application (2016-2021)
5.1.2 Global Codeine Revenue by Application (2016-2021)
5.1.3 Codeine Price by Application (2016-2021)
5.2 Codeine Market Size Forecast by Application (2022-2027)
5.2.1 Global Codeine Sales Forecast by Application (2022-2027)
5.2.2 Global Codeine Revenue Forecast by Application (2022-2027)
5.2.3 Global Codeine Price Forecast by Application (2022-2027)
6 United States by Players, Ingredient and Application
6.1 United States Codeine Market Size YoY Growth 2016-2027
6.1.1 United States Codeine Sales YoY Growth 2016-2027
6.1.2 United States Codeine Revenue YoY Growth 2016-2027
6.1.3 United States Codeine Market Share in Global Market 2016-2027
6.2 United States Codeine Market Size by Players (International and Local Players)
6.2.1 United States Top Codeine Players by Sales (2016-2021)
6.2.2 United States Top Codeine Players by Revenue (2016-2021)
6.3 United States Codeine Historic Market Review by Ingredient (2016-2021)
6.3.1 United States Codeine Sales Market Share by Ingredient (2016-2021)
6.3.2 United States Codeine Revenue Market Share by Ingredient (2016-2021)
6.3.3 United States Codeine Price by Ingredient (2016-2021)
6.4 United States Codeine Market Estimates and Forecasts by Ingredient (2022-2027)
6.4.1 United States Codeine Sales Forecast by Ingredient (2022-2027)
6.4.2 United States Codeine Revenue Forecast by Ingredient (2022-2027)
6.4.3 United States Codeine Price Forecast by Ingredient (2022-2027)
6.5 United States Codeine Historic Market Review by Application (2016-2021)
6.5.1 United States Codeine Sales Market Share by Application (2016-2021)
6.5.2 United States Codeine Revenue Market Share by Application (2016-2021)
6.5.3 United States Codeine Price by Application (2016-2021)
6.6 United States Codeine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Codeine Sales Forecast by Application (2022-2027)
6.6.2 United States Codeine Revenue Forecast by Application (2022-2027)
6.6.3 United States Codeine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Codeine Market Size YoY Growth 2016-2027
7.2 North America Codeine Market Facts & Figures by Country
7.2.1 North America Codeine Sales by Country (2016-2021)
7.2.2 North America Codeine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Codeine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Codeine Market Facts & Figures by Region
8.2.1 Asia Pacific Codeine Sales by Region (2016-2021)
8.2.2 Asia Pacific Codeine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Codeine Market Size YoY Growth 2016-2027
9.2 Europe Codeine Market Facts & Figures by Country
9.2.1 Europe Codeine Sales by Country (2016-2021)
9.2.2 Europe Codeine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Codeine Market Size YoY Growth 2016-2027
10.2 Latin America Codeine Market Facts & Figures by Country
10.2.1 Latin America Codeine Sales by Country (2016-2021)
10.2.2 Latin America Codeine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Codeine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Codeine Market Facts & Figures by Country
11.2.1 Middle East and Africa Codeine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Codeine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Taiji
12.1.1 Taiji Corporation Information
12.1.2 Taiji Description and Business Overview
12.1.3 Taiji Codeine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Taiji Codeine Products Offered
12.1.5 Taiji Recent Development
12.2 Mallinckrodt
12.2.1 Mallinckrodt Corporation Information
12.2.2 Mallinckrodt Description and Business Overview
12.2.3 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Mallinckrodt Codeine Products Offered
12.2.5 Mallinckrodt Recent Development
12.3 TEVA
12.3.1 TEVA Corporation Information
12.3.2 TEVA Description and Business Overview
12.3.3 TEVA Codeine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 TEVA Codeine Products Offered
12.3.5 TEVA Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Description and Business Overview
12.4.3 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson & Johnson Codeine Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Medreich
12.5.1 Medreich Corporation Information
12.5.2 Medreich Description and Business Overview
12.5.3 Medreich Codeine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Medreich Codeine Products Offered
12.5.5 Medreich Recent Development
12.6 Sanofi Aventis
12.6.1 Sanofi Aventis Corporation Information
12.6.2 Sanofi Aventis Description and Business Overview
12.6.3 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sanofi Aventis Codeine Products Offered
12.6.5 Sanofi Aventis Recent Development
12.7 Cipla
12.7.1 Cipla Corporation Information
12.7.2 Cipla Description and Business Overview
12.7.3 Cipla Codeine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cipla Codeine Products Offered
12.7.5 Cipla Recent Development
12.8 Hikma
12.8.1 Hikma Corporation Information
12.8.2 Hikma Description and Business Overview
12.8.3 Hikma Codeine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hikma Codeine Products Offered
12.8.5 Hikma Recent Development
12.9 Pharmaceutical Associates
12.9.1 Pharmaceutical Associates Corporation Information
12.9.2 Pharmaceutical Associates Description and Business Overview
12.9.3 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pharmaceutical Associates Codeine Products Offered
12.9.5 Pharmaceutical Associates Recent Development
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Description and Business Overview
12.10.3 Novartis Codeine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis Codeine Products Offered
12.10.5 Novartis Recent Development
12.11 Taiji
12.11.1 Taiji Corporation Information
12.11.2 Taiji Description and Business Overview
12.11.3 Taiji Codeine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Taiji Codeine Products Offered
12.11.5 Taiji Recent Development
12.12 Mylan
12.12.1 Mylan Corporation Information
12.12.2 Mylan Description and Business Overview
12.12.3 Mylan Codeine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Mylan Products Offered
12.12.5 Mylan Recent Development
12.13 Aristo Pharma GmbH
12.13.1 Aristo Pharma GmbH Corporation Information
12.13.2 Aristo Pharma GmbH Description and Business Overview
12.13.3 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Aristo Pharma GmbH Products Offered
12.13.5 Aristo Pharma GmbH Recent Development
12.14 Lannett Company
12.14.1 Lannett Company Corporation Information
12.14.2 Lannett Company Description and Business Overview
12.14.3 Lannett Company Codeine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Lannett Company Products Offered
12.14.5 Lannett Company Recent Development
12.15 Laboratoire Riva
12.15.1 Laboratoire Riva Corporation Information
12.15.2 Laboratoire Riva Description and Business Overview
12.15.3 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Laboratoire Riva Products Offered
12.15.5 Laboratoire Riva Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Codeine Industry Trends
13.2 Codeine Market Drivers
13.3 Codeine Market Challenges
13.4 Codeine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Codeine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Codeine Market Size Growth Rate by Ingredient, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Single-ingredient Codeine
Table 3. Major Manufacturers of Multi-ingredient Medications
Table 4. Global Codeine Market Size Growth Rate by Application (2021-2027) & (M Units)
Table 5. Global Codeine Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Codeine Sales by Regions (2016-2021) & (M Units)
Table 7. Global Codeine Sales Market Share by Regions (2016-2021)
Table 8. Global Codeine Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Codeine Sales Forecast by Region (2022-2027) & (M Units)
Table 10. Global Codeine Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Codeine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Codeine Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Codeine Sales by Manufacturers (2016-2021) (M Units)
Table 14. Global Codeine Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Codeine Manufacturers by Revenue (US$ Million) in 2020
Table 16. Codeine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Codeine Revenue Share by Manufacturers (2016-2021)
Table 18. Global Codeine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Codeine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Codeine as of 2020)
Table 20. Key Manufacturers Codeine Price (2016-2021) (USD/Unit)
Table 21. Codeine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Codeine Product Type
Table 23. Date of International Manufacturers Enter into Codeine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Codeine Sales by Ingredient (2016-2021) (M Units)
Table 26. Global Codeine Sales Share by Ingredient (2016-2021)
Table 27. Global Codeine Revenue by Ingredient (2016-2021) (US$ Million)
Table 28. Global Codeine Revenue Share by Ingredient (2016-2021)
Table 29. Codeine Average Selling Price (ASP) by Ingredient (2016-2021) & (USD/Unit)
Table 30. Global Codeine Sales Forecast by Ingredient (2022-2027) & (M Units)
Table 31. Global Codeine Sales Market Share Forecast by Ingredient (2022-2027)
Table 32. Global Codeine Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Codeine Revenue Market Share Forecast by Ingredient (2022-2027)
Table 34. Global Codeine Average Selling Price (ASP) Forecast by Ingredient (2022-2027) & (USD/Unit)
Table 35. Global Codeine Sales by Application (2016-2021) (M Units)
Table 36. Global Codeine Sales Share by Application (2016-2021)
Table 37. Global Codeine Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Codeine Revenue Share by Application (2016-2021)
Table 39. Codeine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Codeine Sales Forecast by Application (2022-2027) & (M Units)
Table 41. Global Codeine Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Codeine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Codeine Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Codeine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. United States Codeine Sales (M Units) of Key Companies (2016-2021)
Table 46. United States Codeine Sales Share by Company (2016-2021)
Table 47. United States Codeine Revenue (US$ Million) by Company (2016-2021)
Table 48. United States Codeine Revenue Share by Company (2016-2021)
Table 49. United States Codeine Sales (M Units) by Ingredient (2016-2021)
Table 50. United States Codeine Sales Share by Ingredient (2016-2021)
Table 51. United States Codeine Revenue (US$ Million) Market Share by Ingredient (2016-2021)
Table 52. United States Codeine Price (USD/Unit) by Ingredient (2016-2021)
Table 53. United States Codeine Sales (M Units) by Ingredient (2022-2027)
Table 54. United States Codeine Sales Share by Ingredient (2022-2027)
Table 55. United States Codeine Revenue (US$ Million) Market Share by Ingredient (2022-2027)
Table 56. United States Codeine Revenue Share by Ingredient (2022-2027)
Table 57. United States Codeine Price (USD/Unit) by Ingredient (2022-2027)
Table 58. United States Codeine Sales (M Units) by Application (2016-2021)
Table 59. United States Codeine Sales Share by Application (2016-2021)
Table 60. United States Codeine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. United States Codeine Price (USD/Unit) by Application (2016-2021)
Table 62. United States Codeine Sales (M Units) by Application (2022-2027)
Table 63. United States Codeine Sales Share by Application (2022-2027)
Table 64. United States Codeine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. United States Codeine Revenue Share by Application (2022-2027)
Table 66. United States Codeine Price (USD/Unit) by Application (2022-2027)
Table 67. North America Codeine Sales by Country (2016-2021) & (M Units)
Table 68. North America Codeine Sales Market Share by Country (2016-2021)
Table 69. North America Codeine Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Codeine Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Codeine Sales by Region (2016-2021) & (M Units)
Table 72. Asia Pacific Codeine Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Codeine Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Codeine Revenue Market Share by Region (2016-2021)
Table 75. Europe Codeine Sales by Country (2016-2021) & (M Units)
Table 76. Europe Codeine Sales Market Share by Country (2016-2021)
Table 77. Europe Codeine Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Codeine Revenue Market Share by Country (2016-2021)
Table 79. Latin America Codeine Sales by Country (2016-2021) & (M Units)
Table 80. Latin America Codeine Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Codeine Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Codeine Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Codeine Sales by Country (2016-2021) & (M Units)
Table 84. Middle East and Africa Codeine Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Codeine Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Codeine Revenue Market Share by Country (2016-2021)
Table 87. Taiji Corporation Information
Table 88. Taiji Description and Business Overview
Table 89. Taiji Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. Taiji Codeine Product
Table 91. Taiji Recent Development
Table 92. Mallinckrodt Corporation Information
Table 93. Mallinckrodt Description and Business Overview
Table 94. Mallinckrodt Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Mallinckrodt Product
Table 96. Mallinckrodt Recent Development
Table 97. TEVA Corporation Information
Table 98. TEVA Description and Business Overview
Table 99. TEVA Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. TEVA Product
Table 101. TEVA Recent Development
Table 102. Johnson & Johnson Corporation Information
Table 103. Johnson & Johnson Description and Business Overview
Table 104. Johnson & Johnson Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Johnson & Johnson Product
Table 106. Johnson & Johnson Recent Development
Table 107. Medreich Corporation Information
Table 108. Medreich Description and Business Overview
Table 109. Medreich Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Medreich Product
Table 111. Medreich Recent Development
Table 112. Sanofi Aventis Corporation Information
Table 113. Sanofi Aventis Description and Business Overview
Table 114. Sanofi Aventis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Sanofi Aventis Product
Table 116. Sanofi Aventis Recent Development
Table 117. Cipla Corporation Information
Table 118. Cipla Description and Business Overview
Table 119. Cipla Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Cipla Product
Table 121. Cipla Recent Development
Table 122. Hikma Corporation Information
Table 123. Hikma Description and Business Overview
Table 124. Hikma Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Hikma Product
Table 126. Hikma Recent Development
Table 127. Pharmaceutical Associates Corporation Information
Table 128. Pharmaceutical Associates Description and Business Overview
Table 129. Pharmaceutical Associates Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Pharmaceutical Associates Product
Table 131. Pharmaceutical Associates Recent Development
Table 132. Novartis Corporation Information
Table 133. Novartis Description and Business Overview
Table 134. Novartis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. Novartis Product
Table 136. Novartis Recent Development
Table 137. Apotex Corporation Information
Table 138. Apotex Description and Business Overview
Table 139. Apotex Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. Apotex Product
Table 141. Apotex Recent Development
Table 142. Mylan Corporation Information
Table 143. Mylan Description and Business Overview
Table 144. Mylan Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. Mylan Product
Table 146. Mylan Recent Development
Table 147. Aristo Pharma GmbH Corporation Information
Table 148. Aristo Pharma GmbH Description and Business Overview
Table 149. Aristo Pharma GmbH Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 150. Aristo Pharma GmbH Product
Table 151. Aristo Pharma GmbH Recent Development
Table 152. Lannett Company Corporation Information
Table 153. Lannett Company Description and Business Overview
Table 154. Lannett Company Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 155. Lannett Company Product
Table 156. Lannett Company Recent Development
Table 157. Laboratoire Riva Corporation Information
Table 158. Laboratoire Riva Description and Business Overview
Table 159. Laboratoire Riva Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 160. Laboratoire Riva Product
Table 161. Laboratoire Riva Recent Development
Table 162. Codeine Market Trends
Table 163. Codeine Market Drivers
Table 164. Codeine Market Challenges
Table 165. Codeine Market Restraints
Table 166. Codeine Customers List
Table 167. Codeine Distributors List
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Codeine Product Picture
Figure 2. Global Codeine Sales Market Share by Ingredient in 2020 & 2027
Figure 3. Single-ingredient Codeine Product Picture
Figure 4. Multi-ingredient Medications Product Picture
Figure 5. Global Codeine Sales Market Share by Application in 2020 & 2027
Figure 6. Narcotic Analgesic
Figure 7. Antitussive
Figure 8. Others
Figure 9. Codeine Report Years Considered
Figure 10. Global Codeine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Codeine Market Size 2016-2027 (US$ Million)
Figure 12. Global Codeine Sales 2016-2027 (M Units)
Figure 13. Global Codeine Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Codeine Sales Market Share by Region (2016-2021)
Figure 15. Global Codeine Sales Market Share by Region in 2020
Figure 16. Global Codeine Revenue Market Share by Region (2016-2021)
Figure 17. Global Codeine Revenue Market Share by Region in 2020
Figure 18. Global Codeine Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Codeine Revenue in 2020
Figure 20. Codeine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Codeine Sales Market Share by Ingredient (2016-2021)
Figure 22. Global Codeine Sales Market Share by Ingredient in 2020
Figure 23. Global Codeine Revenue Market Share by Ingredient (2016-2021)
Figure 24. Global Codeine Revenue Market Share by Ingredient in 2020
Figure 25. Global Codeine Sales Market Share by Application (2016-2021)
Figure 26. Global Codeine Sales Market Share by Application in 2020
Figure 27. Global Codeine Revenue Market Share by Application (2016-2021)
Figure 28. Global Codeine Revenue Market Share by Application in 2020
Figure 29. United States Codeine Sales Growth Rate 2016-2027 (M Units)
Figure 30. United States Codeine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States Codeine Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest Codeine Players Market Share by Revenue in Codeine in 2020
Figure 33. United States Codeine Revenue Share by Ingredient (2016-2021)
Figure 34. United States Codeine Revenue Growth Rate by Ingredient in 2016 & 2020
Figure 35. United States Codeine Revenue Share by Application (2016-2021)
Figure 36. United States Codeine Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Codeine Sales Growth Rate 2016-2021 (M Units)
Figure 38. North America Codeine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Codeine Sales Market Share by Country in 2020
Figure 40. North America Codeine Revenue Market Share by Country in 2020
Figure 41. U.S. Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 42. U.S. Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 44. Canada Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Codeine Sales Growth Rate 2016-2021 (M Units)
Figure 46. Europe Codeine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Codeine Sales Market Share by Country in 2020
Figure 48. Europe Codeine Revenue Market Share by Country in 2020
Figure 49. Germany Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 50. Germany Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 52. France Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 54. U.K. Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 56. Italy Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 58. Russia Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Codeine Sales Growth Rate 2016-2021 (M Units)
Figure 60. Asia Pacific Codeine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Codeine Sales Market Share by Region in 2020
Figure 62. Asia Pacific Codeine Revenue Market Share by Region in 2020
Figure 63. China Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 64. China Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 66. Japan Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 68. South Korea Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 70. India Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 72. Australia Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 74. Taiwan Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 76. Indonesia Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 78. Thailand Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 80. Malaysia Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 82. Philippines Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 84. Vietnam Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Codeine Sales Growth Rate 2016-2021 (M Units)
Figure 86. Latin America Codeine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Codeine Sales Market Share by Country in 2020
Figure 88. Latin America Codeine Revenue Market Share by Country in 2020
Figure 89. Mexico Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 90. Mexico Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 92. Brazil Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 94. Argentina Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Codeine Sales Growth Rate 2016-2021 (M Units)
Figure 96. Middle East and Africa Codeine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Codeine Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Codeine Revenue Market Share by Country in 2020
Figure 99. Turkey Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 100. Turkey Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 102. Saudi Arabia Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. UAE Codeine Sales Growth Rate (2016-2021) (M Units)
Figure 104. UAE Codeine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Codeine Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This
  • Global Divalproex Sodium Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81
    Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
  • Global Divalproex Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
  • Global Quetiapine Fumarate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
  • Global Clozapine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Trazodone Hydrochloride (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
  • Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93
    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
  • Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
  • Global Risperidone Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......
  • Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
    Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101
    Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs